Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

41.18
Delayed Data
As of Aug 28
 -0.85 / -2.02%
Today’s Change
30.13
Today|||52-Week Range
52.58
-19.02%
Year-to-Date
No recent news for Enanta Pharmaceuticals Inc.

Today’s Trading

Previous close42.03
Today’s open41.74
Day’s range40.57 - 42.11
Volume231,011
Average volume (3 months)316,540
Market cap$770.6M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+125.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+48.94%
P/E ratio11.6
Price/Sales15.90
Price/Book5.15

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc+0.91+3.46%
RVNCRevance Therapeutics...-0.01-0.03%
EPZMEpizyme Inc+2.60+14.86%
SGYPSynergy Pharmaceutic...+0.01+0.14%
Data as of 4:14pm ET, 08/28/2015

Financials

Next reporting dateNovember 23, 2015
EPS forecast (this quarter)$0.17
Annual revenue (last year)$47.7M
Annual profit (last year)$34.4M
Net profit margin72.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
Chief Financial Officer &
Senior VP-Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts

Partner Offers